PT  - JOURNAL ARTICLE
ED  - Antman, Elliott
TI  - Enoxaparin Strategy Appears to Reduce Reinfarction Better than Commonly Administered Unfractionated Heparin in ST Elevation Myocardial Infarction
DP  - 2006 May 01
TA  - MD Conference Express
PG  - 20--20
VI  - 6
IP  - 1
4099  - http://mdc.sagepub.com/content/6/1/20.short
4100  - http://mdc.sagepub.com/content/6/1/20.full
AB  - Treatment with enoxaparin (a low molecular weight heparin) throughout hospitalization (up to 8 days) significantly reduced the risk of death or nonfatal reinfarction, compared to administration of unfractionated heparin (UFH) for 48 hours in patients with ST-elevation myocardial infarction (STEMI) undergoing fibrinolytic therapy, according to findings from the multicenter multinational ExTRACT-TIMI 25 trial lead by the investigators from the Brigham and Women's Hospital.